Laboratory Corp. of America Stock Price, News & Analysis (NYSE:LH)

$170.23 -0.98 (-0.57 %)
(As of 02/23/2018 11:19 AM ET)
Previous Close$171.21
Today's Range$169.78 - $172.48
52-Week Range$134.19 - $181.71
Volume136,887 shs
Average Volume643,005 shs
Market Capitalization$17.46 billion
P/E Ratio23.64
Dividend YieldN/A
Beta0.92

About Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America logoLaboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorHealthcare
SymbolNYSE:LH
CUSIP50540R40
Phone+1-336-2291127

Debt

Debt-to-Equity Ratio0.93%
Current Ratio1.31%
Quick Ratio1.20%

Price-To-Earnings

Trailing P/E Ratio23.6435506241331
Forward P/E Ratio14.76
P/E Growth1.47

Sales & Book Value

Annual Sales$10.44 billion
Price / Sales1.66
Cash Flow$14.73 per share
Price / Cash11.56
Book Value$67.09 per share
Price / Book2.54

Profitability

Trailing EPS$7.21
Net Income$1.27 billion
Net Margins12.15%
Return on Equity16.30%
Return on Assets6.38%

Miscellaneous

Employees52,000
Outstanding Shares101,800,000

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) posted its quarterly earnings results on Tuesday, February, 6th. The medical research company reported $2.45 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.38 by $0.07. The medical research company earned $2.70 billion during the quarter, compared to the consensus estimate of $2.70 billion. Laboratory Corp. of America had a return on equity of 16.30% and a net margin of 12.15%. The business's quarterly revenue was up 13.2% on a year-over-year basis. During the same period last year, the business earned $2.15 EPS. View Laboratory Corp. of America's Earnings History.

When will Laboratory Corp. of America make its next earnings announcement?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Tuesday, April, 24th 2018. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY18 earnings guidance on Tuesday, February, 6th. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus estimate of $10.60. The company issued revenue guidance of $11.41-11.62 billion (+9.5-11.5%), compared to the consensus revenue estimate of $10.96 billion.

Where is Laboratory Corp. of America's stock going? Where will Laboratory Corp. of America's stock price be in 2018?

15 Wall Street analysts have issued 1-year price objectives for Laboratory Corp. of America's stock. Their predictions range from $146.00 to $205.00. On average, they expect Laboratory Corp. of America's stock price to reach $180.07 in the next year. View Analyst Ratings for Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:

  • David P. King, Chairman of the Board, President, Chief Executive Officer (Age 61)
  • Glenn A. Eisenberg, Chief Financial Officer, Executive Vice President
  • John D. Ratliff, Chief Executive Officer - Covance Drug Development (Age 57)
  • Lisa J. Uthgenannt, Chief Human Resource Officer (Age 56)
  • Edward T. Dodson, Senior Vice President, Chief Accounting Officer, Principal Accounting Officer (Age 63)
  • Lance V. Berberian, Senior Vice President, Chief Information Officer (Age 54)
  • F. Samuel Eberts III, Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer (Age 57)
  • Robert E. Mittelstaedt Jr., Lead Independent Director (Age 73)
  • Kerrii B. Anderson, Independent Director (Age 60)
  • Jean-Luc Belingard, Independent Director (Age 68)

Who owns Laboratory Corp. of America stock?

Laboratory Corp. of America's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.83%), Boston Partners (5.17%), UBS Asset Management Americas Inc. (1.76%), Iridian Asset Management LLC CT (1.59%), Ariel Investments LLC (1.20%) and Geode Capital Management LLC (1.10%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Dwight Gary Gilliland, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Who sold Laboratory Corp. of America stock? Who is selling Laboratory Corp. of America stock?

Laboratory Corp. of America's stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, HealthCor Management L.P., Schroder Investment Management Group, APG Asset Management N.V., TIAA CREF Investment Management LLC, Westwood Management Corp IL, Bank of Montreal Can and OppenheimerFunds Inc.. Company insiders that have sold Laboratory Corp. of America company stock in the last year include Adam H Schechter, David P King, Dwight Gary Gilliland, F Samuel Eberts III, Glenn A Eisenberg, Jean-Luc Belingard, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Who bought Laboratory Corp. of America stock? Who is buying Laboratory Corp. of America stock?

Laboratory Corp. of America's stock was bought by a variety of institutional investors in the last quarter, including Boston Partners, Bridger Management LLC, PGGM Investments, BlackRock Inc., Global Thematic Partners LLC, Calamos Advisors LLC, Amundi Pioneer Asset Management Inc. and Renaissance Technologies LLC. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy Laboratory Corp. of America stock?

Shares of Laboratory Corp. of America can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of Laboratory Corp. of America stock can currently be purchased for approximately $170.51.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $17.46 billion and generates $10.44 billion in revenue each year. The medical research company earns $1.27 billion in net income (profit) each year or $7.21 on an earnings per share basis. Laboratory Corp. of America employs 52,000 workers across the globe.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 S MAIN ST, BURLINGTON, NC 27215-5837, United States. The medical research company can be reached via phone at +1-336-2291127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (LH)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  334 (Vote Outperform)
Underperform Votes:  393 (Vote Underperform)
Total Votes:  727
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Laboratory Corp. of America (NYSE:LH) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.622.582.55
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $180.07$172.92$168.64$160.36
Price Target Upside: 8.83% upside1.63% downside11.61% upside2.53% upside

Laboratory Corp. of America (NYSE:LH) Consensus Price Target History

Price Target History for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE:LH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2018CitigroupBoost Price TargetNeutral -> Neutral$161.00 -> $184.00MediumView Rating Details
2/8/2018Robert W. BairdSet Price TargetNeutral -> Hold$150.00 -> $183.00HighView Rating Details
2/7/2018Craig HallumReiterated RatingBuy$180.00 -> $204.00LowView Rating Details
1/29/2018Goldman Sachs GroupInitiated CoverageNeutral -> Buy$128.00 -> $205.00LowView Rating Details
1/24/2018MizuhoSet Price TargetHold$178.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$176.00HighView Rating Details
12/13/2017BarclaysReiterated RatingBuy$195.00LowView Rating Details
11/24/2017Jefferies GroupSet Price TargetHold$167.00LowView Rating Details
10/26/2017Deutsche BankBoost Price TargetBuy$170.00 -> $172.00N/AView Rating Details
10/12/2017SunTrust BanksReiterated RatingBuy$190.00N/AView Rating Details
10/12/2017Wells Fargo & CoInitiated CoverageMarket Perform -> Outperform$175.00N/AView Rating Details
9/26/2017KeyCorpReiterated RatingHoldLowView Rating Details
9/11/2017Canaccord GenuityReiterated RatingBuy$175.00 -> $180.00MediumView Rating Details
8/10/2017Morgan StanleyBoost Price TargetOverweight$154.00 -> $166.00LowView Rating Details
7/13/2017Credit Suisse GroupDowngradeHold$146.00LowView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
3/4/2016William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Laboratory Corp. of America (NYSE:LH) Earnings History and Estimates Chart

Earnings by Quarter for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE LH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/23/2018$2.58N/AView Earnings Details
2/6/2018Q4 2017$2.38$2.45$2.70 billion$2.70 billionViewListenView Earnings Details
10/25/2017Q3 2017$2.38$2.46$2.55 billion$2.60 billionViewN/AView Earnings Details
7/26/2017Q2 2017$2.40$2.47$2.47 billion$2.50 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.41 billion$2.41 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.49 billion$1.51 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
10/21/2010Q3 2010$1.40$1.47ViewN/AView Earnings Details
7/22/2010Q2 2010$1.42$1.46ViewN/AView Earnings Details
4/21/2010Q1 2010$1.31$1.30ViewN/AView Earnings Details
2/11/2010Q4 2009$1.15$1.16ViewN/AView Earnings Details
10/22/2009Q3 2009$1.15$1.22ViewN/AView Earnings Details
7/23/2009Q2 2009$1.27$1.30ViewN/AView Earnings Details
4/23/2009Q1 2009$1.17$1.22ViewN/AView Earnings Details
2/12/2009Q4 2008$1.09$1.10ViewN/AView Earnings Details
10/23/2008Q3 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q2 2008$1.24$1.24ViewN/AView Earnings Details
4/24/2008Q1 2008$1.14$1.14ViewN/AView Earnings Details
2/7/2008Q4 2007$1.00$1.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Laboratory Corp. of America (NYSE:LH) Earnings Estimates

2018 EPS Consensus Estimate: $10.86
2019 EPS Consensus Estimate: $11.76
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$2.34$2.75$2.48
Q2 20185$2.63$2.98$2.77
Q3 20185$2.66$2.99$2.82
Q4 20185$2.56$3.07$2.79
Q1 20192$2.56$2.76$2.66
Q2 20192$2.82$3.22$3.02
Q3 20192$2.94$3.23$3.09
Q4 20192$2.71$3.28$3.00
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corp. of America (NYSE:LH)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Laboratory Corp. of America (NYSE LH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.90%
Institutional Ownership Percentage: 90.41%
Insider Trades by Quarter for Laboratory Corp. of America (NYSE:LH)
Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE LH) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2018Glenn A EisenbergCFOSell8,400$167.36$1,405,824.0015,931View SEC Filing  
2/8/2018Adam H SchechterDirectorSell1,263$169.29$213,813.277,297View SEC Filing  
10/30/2017Dwight Gary GillilandDirectorSell971$153.52$149,067.923,501View SEC Filing  
9/6/2017David P KingCEOSell44,687$156.86$7,009,602.82258,753View SEC Filing  
9/5/2017David P. KingCEOSell132,713$157.06$20,843,903.78View SEC Filing  
8/25/2017F Samuel Eberts IIIInsiderSell31,500$155.22$4,889,430.0031,894View SEC Filing  
8/11/2017R Sanders WilliamsDirectorSell3,100$156.88$486,328.0010,073View SEC Filing  
8/1/2017Glenn A EisenbergCFOSell5,968$159.46$951,657.2818,122View SEC Filing  
8/1/2017Lisa J. UthgenanntInsiderSell5,000$160.00$800,000.00View SEC Filing  
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.925,789View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.4832,935View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.0012,556View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.0018,208View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.003,660View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.008,668View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.8012,340View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00271,210View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.642,717View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.1524,751View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.9258,191View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.8818,529View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.7626,410View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.0430,722View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.4018,066View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.1023,454View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.3518,436View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.0427,509View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.7518,066View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.1019,281View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.004,176View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.5213,958View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.5625,821View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.2019,400View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.6728,188View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.6028,188View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.0063,699View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.0063,628View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.0063,628View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.0063,628View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.947,015View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Laboratory Corp. of America (NYSE LH) News Headlines

Source:
DateHeadline
Heres Why You Should Invest in LabCorp (LH) Stock Right NowHere's Why You Should Invest in LabCorp (LH) Stock Right Now
www.zacks.com - February 23 at 9:13 AM
Laboratory Corp. of America Holdings (LH) Expected to Announce Quarterly Sales of $2.74 BillionLaboratory Corp. of America Holdings (LH) Expected to Announce Quarterly Sales of $2.74 Billion
www.americanbankingnews.com - February 21 at 6:22 AM
Report: Triad city sees 41 percent jump in available tech jobsReport: Triad city sees 41 percent jump in available tech jobs
www.bizjournals.com - February 20 at 5:01 PM
LabCorp to Host Investor and Analyst Day on February 27, 2018LabCorp to Host Investor and Analyst Day on February 27, 2018
finance.yahoo.com - February 20 at 8:58 AM
Laboratory Corp. of America Holdings (LH) Expected to Announce Earnings of $2.59 Per ShareLaboratory Corp. of America Holdings (LH) Expected to Announce Earnings of $2.59 Per Share
www.americanbankingnews.com - February 19 at 12:16 PM
Laboratory Corp. of America Holdings (LH) Expected to Earn FY2020 Earnings of $13.01 Per ShareLaboratory Corp. of America Holdings (LH) Expected to Earn FY2020 Earnings of $13.01 Per Share
www.americanbankingnews.com - February 19 at 8:48 AM
Financial Comparison: Surgical Care Affiliates (SCAI) and Laboratory Corp. of America (LH)Financial Comparison: Surgical Care Affiliates (SCAI) and Laboratory Corp. of America (LH)
www.americanbankingnews.com - February 17 at 1:16 AM
Cancer Genetics (CGIX) versus Laboratory Corp. of America (LH) Critical ReviewCancer Genetics (CGIX) versus Laboratory Corp. of America (LH) Critical Review
www.americanbankingnews.com - February 14 at 7:18 PM
Glenn A. Eisenberg Sells 8,400 Shares of Laboratory Corp. of America Holdings (LH) StockGlenn A. Eisenberg Sells 8,400 Shares of Laboratory Corp. of America Holdings (LH) Stock
www.americanbankingnews.com - February 14 at 3:14 PM
Laboratory Corp. of America Holdings (LH) Receives Consensus Rating of "Buy" from BrokeragesLaboratory Corp. of America Holdings (LH) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - February 14 at 3:36 AM
LabCorp CEO: Amazon sneezes, health care catches a coldLabCorp CEO: 'Amazon sneezes, health care catches a cold'
finance.yahoo.com - February 12 at 4:23 PM
Citigroup Raises Laboratory Corp. of America (LH) Price Target to $184.00Citigroup Raises Laboratory Corp. of America (LH) Price Target to $184.00
www.americanbankingnews.com - February 10 at 6:22 PM
Laboratory Corp. of America (LH) Lifted to Buy at Zacks Investment ResearchLaboratory Corp. of America (LH) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - February 9 at 8:58 PM
Insider Selling: Laboratory Corp. of America Holdings (LH) Director Sells 1,263 Shares of StockInsider Selling: Laboratory Corp. of America Holdings (LH) Director Sells 1,263 Shares of Stock
www.americanbankingnews.com - February 9 at 6:32 PM
Laboratory Corp. of America Holdings to Post Q1 2018 Earnings of $2.75 Per Share, KeyCorp Forecasts (LH)Laboratory Corp. of America Holdings to Post Q1 2018 Earnings of $2.75 Per Share, KeyCorp Forecasts (LH)
www.americanbankingnews.com - February 9 at 8:00 AM
Q1 2018 EPS Estimates for Laboratory Corp. of America Holdings (LH) Increased by AnalystQ1 2018 EPS Estimates for Laboratory Corp. of America Holdings (LH) Increased by Analyst
www.americanbankingnews.com - February 9 at 8:00 AM
Robert W. Baird Reiterates "$183.00" Price Target for Laboratory Corp. of America (LH)Robert W. Baird Reiterates "$183.00" Price Target for Laboratory Corp. of America (LH)
www.americanbankingnews.com - February 8 at 11:50 PM
Laboratory Corp. of America Holdings Forecasted to Earn Q1 2019 Earnings of $2.56 Per Share (LH)Laboratory Corp. of America Holdings Forecasted to Earn Q1 2019 Earnings of $2.56 Per Share (LH)
www.americanbankingnews.com - February 8 at 3:52 PM
Analysts Offer Predictions for Laboratory Corp. of America Holdings Q3 2018 Earnings (LH)Analysts Offer Predictions for Laboratory Corp. of America Holdings' Q3 2018 Earnings (LH)
www.americanbankingnews.com - February 8 at 11:38 AM
Laboratory Corp. of America (LH) Receives "Buy" Rating from Craig HallumLaboratory Corp. of America (LH) Receives "Buy" Rating from Craig Hallum
www.americanbankingnews.com - February 7 at 1:33 PM
Laboratory Corporation of America (LH) PT Raised to $195 at Deutsche BankLaboratory Corporation of America (LH) PT Raised to $195 at Deutsche Bank
www.streetinsider.com - February 7 at 9:19 AM
Laboratory Corp. of America (LH) Scheduled to Post Earnings on WednesdayLaboratory Corp. of America (LH) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - February 7 at 2:32 AM
LabCorp (LH) Q4 Earnings Beat Estimates, 18 View PromisingLabCorp (LH) Q4 Earnings Beat Estimates, '18 View Promising
www.zacks.com - February 6 at 4:20 PM
Laboratory Corp. of America (LH) Releases FY18 Earnings GuidanceLaboratory Corp. of America (LH) Releases FY18 Earnings Guidance
www.americanbankingnews.com - February 6 at 9:24 AM
LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 GuidanceLabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance
finance.yahoo.com - February 6 at 9:14 AM
LabCorp beats Street 4Q forecastsLabCorp beats Street 4Q forecasts
finance.yahoo.com - February 6 at 9:14 AM
LabCorp (LH) Tops Q4 Earnings & Misses Revenue EstimatesLabCorp (LH) Tops Q4 Earnings & Misses Revenue Estimates
finance.yahoo.com - February 6 at 9:14 AM
Laboratory Corp. of America (LH) Releases  Earnings Results, Beats Expectations By $0.07 EPSLaboratory Corp. of America (LH) Releases Earnings Results, Beats Expectations By $0.07 EPS
www.americanbankingnews.com - February 6 at 8:50 AM
Laboratory Corp. of America (LH) Upgraded at ValuEngineLaboratory Corp. of America (LH) Upgraded at ValuEngine
www.americanbankingnews.com - February 4 at 11:54 PM
Laboratory Corp. of America Holdings (LH) Expected to Announce Earnings of $2.37 Per ShareLaboratory Corp. of America Holdings (LH) Expected to Announce Earnings of $2.37 Per Share
www.americanbankingnews.com - February 2 at 11:40 AM
Will Covance Drug Development Drive LabCorp (LH) Q4 Earnings?Will Covance Drug Development Drive LabCorp (LH) Q4 Earnings?
www.zacks.com - January 31 at 9:36 AM
Laboratory Corp. of America (LH) to Release Earnings on TuesdayLaboratory Corp. of America (LH) to Release Earnings on Tuesday
www.americanbankingnews.com - January 30 at 4:56 AM
Laboratory Corp. of America (LH) Research Coverage Started at Goldman Sachs GroupLaboratory Corp. of America (LH) Research Coverage Started at Goldman Sachs Group
www.americanbankingnews.com - January 29 at 6:02 PM
Top Analyst Upgrades and Downgrades: AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp, Splunk and MoreTop Analyst Upgrades and Downgrades: AbbVie, Apple, Exact Sciences, Freeport-McMoran, Laboratory Corp, Splunk and More
www.msn.com - January 29 at 9:23 AM
Laboratory Corp. of America Holdings (LH) Forecasted to Post FY2018 Earnings of $11.63 Per ShareLaboratory Corp. of America Holdings (LH) Forecasted to Post FY2018 Earnings of $11.63 Per Share
www.americanbankingnews.com - January 25 at 12:28 PM
Mizuho Analysts Give Laboratory Corp. of America (LH) a $178.00 Price TargetMizuho Analysts Give Laboratory Corp. of America (LH) a $178.00 Price Target
www.americanbankingnews.com - January 24 at 11:18 PM
Agree To Buy Laboratory Corporation of America Holdings At $175, Earn 16.9% Annualized Using OptionsAgree To Buy Laboratory Corporation of America Holdings At $175, Earn 16.9% Annualized Using Options
www.nasdaq.com - January 22 at 5:58 PM
Laboratory Corp. of America Holdings (LH) Receives Average Rating of "Buy" from BrokeragesLaboratory Corp. of America Holdings (LH) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 20 at 3:38 AM
LabCorp Named to FORTUNE Magazines 2018 List of ‘World’s Most Admired Companies’LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’
finance.yahoo.com - January 19 at 5:51 PM
Laboratory Corp. of America Holdings (LH) Expected to Announce Quarterly Sales of $2.70 BillionLaboratory Corp. of America Holdings (LH) Expected to Announce Quarterly Sales of $2.70 Billion
www.americanbankingnews.com - January 18 at 8:38 AM
Canaccord Genuity Issues Top 5 Diagnostics Picks for 2018Canaccord Genuity Issues Top 5 Diagnostics Picks for 2018
247wallst.com - January 16 at 5:18 PM
Laboratory Corp. of America (LH) Downgraded by ValuEngineLaboratory Corp. of America (LH) Downgraded by ValuEngine
www.americanbankingnews.com - January 10 at 1:38 PM
Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics CompaniesCovance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies
finance.yahoo.com - January 8 at 9:53 AM
Laboratory Corp. of America (LH) Earns Outperform Rating from Analysts at Evercore ISILaboratory Corp. of America (LH) Earns Outperform Rating from Analysts at Evercore ISI
www.americanbankingnews.com - January 4 at 5:04 PM
LabCorp is Scheduled to Present at the 36th Annual J.P. Morgan Healthcare ConferenceLabCorp is Scheduled to Present at the 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 5:22 PM
Form 8-K LABORATORY CORP OF AMERI For: Jan 02 - StreetInsider.comForm 8-K LABORATORY CORP OF AMERI For: Jan 02 - StreetInsider.com
www.streetinsider.com - January 3 at 8:41 AM
Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
finance.yahoo.com - January 2 at 9:27 AM
Laboratory Corp. of America (LH) Given a $165.00 Price Target at MizuhoLaboratory Corp. of America (LH) Given a $165.00 Price Target at Mizuho
www.americanbankingnews.com - December 30 at 5:14 PM
Zacks: Analysts Expect Laboratory Corp. of America Holdings (LH) to Announce $2.37 EPSZacks: Analysts Expect Laboratory Corp. of America Holdings (LH) to Announce $2.37 EPS
www.americanbankingnews.com - December 30 at 3:14 PM
2017s top stories: LabCorp continues acquisition spree, but faces reimbursement headwinds2017's top stories: LabCorp continues acquisition spree, but faces reimbursement headwinds
finance.yahoo.com - December 28 at 1:55 PM

SEC Filings

Laboratory Corp. of America (NYSE:LH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Laboratory Corp. of America (NYSE:LH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Laboratory Corp. of America (NYSE LH) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.